Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program. Go to Publication You Might Also Like “Chennai Declaration”: 5-year plan to tackle the challenge of anti-microbial resistance. July 17, 2014 Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai. October 30, 2014 A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. November 15, 2017 ARDS: predicting mortality and improving survival. September 9, 2003 Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016
“Chennai Declaration”: 5-year plan to tackle the challenge of anti-microbial resistance. July 17, 2014
Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai. October 30, 2014
A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective. November 15, 2017
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. March 6, 2016